Entrepreneurship

Esser will work with scientists to accelerate the development of new medicines and treatments for illnesses like cancer and Alzheimer's.

One of Esser's responsibilities will be to foster an "ecosystem of innovation" that will attract biotechnology and pharmaceutical companies to Central Virginia and the greater Commonwealth.

Generosity from anonymous donors will support research and aid in the development of new treatments for hard-to-treat or incurable diseases, to the benefit of patients everywhere.

UVA Licensing & Ventures Group helps UVA researchers secure patents for their inventions and launch start-up companies.

A statewide biopharma boom is fueled by talent emerging from Virginia's universities, which provide a steady pipeline of specialized labor.

The Virginia Catalyst Fund encourages collaboration with over 30 industry partners in collaboration with Virginia universities, including UVA.

Explore 2022's first quarter edition of the Virginia Economic Review featuring a story on UVA and its support for the life sciences industry in Charlottesville (p. 32).

Professor Gregory B. Fairchild is the first director of Northern Virginia operations for the University of Virginia.

Darden's Executive MBA and Global Executive MBA programs will now operate primarily from a new state-of-the-art facility in the Rosslyn district of Arlington, VA.

UVA, the Virginia Economic Development Partnership, and Virginia Community Capital offer the Resilience Award to companies in Virginia's economically challenged communities. Winners receive a scholarship to a Darden Executive Education program.